CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 678.3	$ 322.4
Short-term investments	6.6	0.0
Accounts receivable, net	362.2	357.2
Inventories	577.2	509.6
Other current assets	172.0	115.1
Total current assets	1,796.3	1,304.3
Property, plant and equipment, net	306.1	270.6
Goodwill	293.0	275.7
Intangible assets, net	233.2	218.7
Operating lease assets	65.6
Deferred tax assets	60.5	50.9
Other long-term assets	16.8	8.4
Total assets	2,771.5	2,128.6
Current liabilities:
Current portion of long-term debt	0.5	18.5
Accounts payable	118.4	104.5
Customer advances	137.9	124.4
Other current liabilities	388.8	351.9
Total current liabilities	645.6	599.3
Long-term debt	812.8	322.6
Long-term deferred revenue	42.8	38.3
Deferred tax liabilities	48.8	51.1
Operating lease liabilities	47.0
Accrued pension	122.4	90.5
Other long-term liabilities	113.9	99.1
Commitments and contingencies (Note 15)
Redeemable noncontrolling interest	21.1	22.6
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding at December 31, 2019 and 2018
Common stock, $0.01 par value 260,000,000 shares authorized, 173,502,375 and 172,634,220 shares issued and 154,155,798 and 156,609,340 outstanding at December 31, 2019 and 2018, respectively	1.7	1.7
Treasury stock at cost, 19,346,577 and 16,024,880 shares at December 31, 2019 and 2018, respectively	(543.8)	(401.5)
Additional paid-in capital	199.7	176.9
Retained earnings	1,274.7	1,102.5
Accumulated other comprehensive (loss) income	(25.5)	17.0
Total shareholders' equity attributable to Bruker Corporation	906.8	896.6
Noncontrolling interest in consolidated subsidiaries	10.3	8.5
Total shareholders' equity	917.1	905.1
Total liabilities and shareholders' equity	$ 2,771.5	$ 2,128.6